ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester
Newer Antiseizure Medications Less Likely to Be Associated With Major Malformations in Infants
Maternal use of valproate, phenobarbital, and topiramate early in pregnancy linked to increased risk versus lamotrigine use
Oral Ondansetron Beneficial for Pediatric Gastroenteritis-Linked Vomiting
Lower risk for moderate-to-severe gastroenteritis seen during seven days after enrollment with oral ondansetron versus placebo
Fewer Opioids Being Prescribed for Low Back Pain in the Emergency Department
Opioids administered or prescribed in 35.0 and 32.5 percent of U.S. visits in 2016, respectively, compared with 24.5 and 13.5 percent in 2022
2020 to 2024 Saw Drop in Flu Vaccine Uptake Among U.S. Adults
Biggest declines seen in populations usually associated with higher vaccine uptake
Few Discontinuation Symptoms Reported After Stopping Antidepressants
Reported symptoms included dizziness, nausea, vertigo, nervousness
GLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD Complications
Risk ratios were 1.27 and 1.55 for GERD and its complications during a median follow-up of three years for GLP-1 RA versus SGLT-2 inhibitor users
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
Increased cardiovascular risk over five years also seen in association with delayed diagnosis
Vaporized Nicotine Products More Effective Than Nicotine Replacement Therapy
Verified six-month continuous abstinence rate 9.6 percent in NRT group and 28.4 percent in VNP group
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
89 percent of 509 patients would have been ineligible for MajesTEC-1 trial; estimated median PFS was 5.8 months
